Biomarkers to improve functional outcome prediction after ischemic stroke: Results from the SICFAIL, STRAWINSKI, and PREDICT studies.
Felipe A MontellanoViktoria RückerKathrin UngethümAnna PenalbaBenjamin HotterMarina GiraltSilke WiedmannDaniel MackenrodtCaroline MorbachStefan FrantzStefan StörkWilliam N WhiteleyChristoph KleinschnitzAndreas MeiselJoan MontanerKarl Georg HaeuslerPeter U HeuschmannPublished in: European stroke journal (2024)
Copeptin, NT-proBNP, and MR-proANP improved modest but consistently the predictive performance of established prognostic scores in patients with mild AIS. Copeptin was most consistently associated with poor outcome in patients with moderate to severe AIS, although its added prognostic value was less obvious.